Q2 2025 Zydus Lifesciences Ltd Earnings Call Transcript
For today's call we have with us Dr. Sharvil P. Patel, managing director, Nitinkumar Parekh , Chief Financial Officer, Mr Arvind Bothra, head of investor relations and Mr Alo G from the managing director's office.
Let me now give you a broad overview of the developments during the quarter.
I'm happy to inform you that we delivered strong double digit growth during the quarter on the back of sustained growth across all our key businesses.
Our India branded formulations business continued to outgrow the market with 10% year on year growth driven by healthy volumes and contribution from new products.
The consumer wellness business continued to see robust demand in all categories.
The US formulations business continued its upward journey with a robust year on year growth driven by volume expansion and new products launched over the last 12 months, the international formulations business comprising of the emerging markets and Europe also delivered strong growth on the back of resilient demand across
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |